RAP 0.00% 20.5¢ resapp health limited

Ann: Update on US FDA De Novo Classification Request, page-10

  1. 3,857 Posts.
    lightbulb Created with Sketch. 437
    Can only be harmful with the likelihood of a misdiagnosis. Obviously the test results made it more likely to be harmful than not.....why didn't Experien see this with all their experience and 99% success rate? They have a lot to answer for. I'm gutted.
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.